Skip to content

Study on navauppu mezhugu in dysmenorrhoea

A pilot clinical trial to evaluate the therapeutic efficacy of the shastric siddha formulation navauppu mezhugu in soodhagavayu-dysmenorrhoea

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/06/008938
Enrollment
10
Registered
2017-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Lower abdominal pain or pelvic pain during menstrual cycle Backache

Interventions

Intervention1: Navauppu mezhugu: INGREDIENTS: 1.Suththi seitha Sotruppu(Sodium chloride) 2.Suththi seitha Indhuppu(Rock salt) 3.Suththi seitha Vediuppu(Potassium nitrate) 4.Suththi seitha kalluppu(So

Sponsors

Ayothidas pandithar hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Lower abdominal or pelvic pain during menstrual cycle 2) Functional pain scale 3-5 3) Backache

Exclusion criteria

Exclusion criteria: 1) Any major systemic illness 2) Hypertension 3) Renal disorder 4) Malignant tumor 5) vulnerable group

Design outcomes

Primary

MeasureTime frame
Improved pain score reduced from 5-3 to 0-2 No improvement pain score not reduced below 3Timepoint: 1) Total period â?? 1 1/2 years or till the completion of the study whichever is earlier 2) Recruitment for the study will be for 1 year. 3) Treatment duration for each patient- 12 days/4 cycles 4) Follow up period after drug treatment for each patient -2 months 5) Data entry analysis â?? 2 months 6) Report preparation and submission â?? 2months

Secondary

MeasureTime frame
Complete clearance or reduction of size of uterine fibroids adenomyosis endometriosis ovarian cyst including associated symptoms No clinical improvementTimepoint: 1) Total period â?? 1 1/2 years or till the completion of the study whichever is earlier 2) Recruitment for the study will be for 1 year. 3) Treatment duration for each patient- 12 days/4 cycles 4) Follow up period after drug treatment for each patient -2 months 5) Data entry analysis â?? 2 months 6) Report preparation and submission â?? 2months

Countries

India

Contacts

Public ContactDrSathiyabama

National Institute of Siddha

Christianvijila@gmail.com9489912041

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026